Pharmacy Data Migration Checklist: 7 Domains Before Go-Live

There is a particular kind of stress that comes with leading an enterprise pharmacy migration, and it is not the stress of the migration itself. It is the weeks before it, when you know the cutover date is approaching, when every stakeholder has a different definition of ready, and when the gap between what has been planned and what has actually been confirmed starts to feel uncomfortably wide. That gap is where migrations run into trouble, and it is exactly what a well-built pharmacy data migration checklist is designed to close.

This checklist covers seven domains that enterprise pharmacy organizations need to work through before any data moves to the new system. It is written for health systems, retail chains, LTC pharmacy operators, specialty pharmacies, mail-fulfillment operations, PSAOs, and multi-location independents because the complexity those organizations carry into a migration is categorically different from what a single-site conversion involves. The data inconsistencies run deeper, the regulatory surface is wider, and the cost of a gap that would be a minor inconvenience at one location becomes an operational problem replicated across twenty, forty or a hundred.

Each domain below is grounded in real failure patterns, not theoretical risk. Work through every item, assign individual ownership, confirm sign-off in writing, and treat nothing unresolved as acceptable on the other side of go-live.

 

Domain 1: Data Governance and Ownership

Governance tends to get treated as the administrative part of a migration, the paperwork that happens before the real work starts. In practice, it is the scaffolding that holds everything else together, and when it is weak or absent, the effects show up everywhere else on this checklist in the form of decisions that never get made, conflicts that never get resolved, and items that everyone assumed someone else was handling.

In multi-location enterprises, data ownership disputes are one of the most reliable sources of pre-migration delay. Two sites have conflicting patient records, and no one has the authority to decide which is authoritative. A department lead believes their team’s sign-off is sufficient for a domain that actually requires executive authorization. A timeline gets approved by IT leadership without the compliance officer having reviewed what the timeline requires of their team. None of these are unusual situations. They are predictable consequences of starting a migration without a clear governance structure, and the pharmacy data migration checklist has to begin here because everything downstream depends on it.

 

Checklist: Data Governance

• The executive sponsor was identified and formally assigned to the migration initiative
• Migration scope document reviewed and approved at the appropriate authority level
• Data stewardship roles assigned for each category: clinical, financial, compliance, and operational
• Records retention policy reviewed and confirmed current against state board and federal requirements
• Data ownership confirmed for every location in the migration scope
• Escalation path defined for data conflicts that cannot be resolved at the domain level
• Migration timeline formally approved by all department leads
• Post-migration audit accountability is assigned to a named individual, not a team

 

A useful test for this domain: take any unresolved item from the list above and ask who has the authority to make the final call on it. If the answer is a department or a committee rather than a specific person, governance is not complete. Committees discuss. Named individuals decide and are accountable for those decisions.

 

Domain 2: Legacy System Audit and Data Inventory

One of the most consistent surprises in enterprise pharmacy migrations is discovering, well into the project, that the data environment is more complex than anyone at the organizational level knew it was. This is not negligence. It is what happens when dozens of locations have been operating semi-independently for years, each one making small accommodations to their workflows, adding fields that the legacy system did not natively support, building integrations with local vendors, and developing data entry conventions that made sense to the people who created them but were never documented for anyone else.

From the top, the organization looks like it is running on one platform. Under a formal audit, it often looks like it is running on one platform with years of locally accumulated variation built on top of it. The legacy system audit is where that variation becomes visible, and the only question is whether you want it to become visible during a controlled pre-migration review or during go-live when a workflow breaks because a field that a site had been using for three years was never included in the migration scope.

 

Checklist: Legacy System Audit

• Full inventory of all data sources in scope, including structured and unstructured records
• Legacy database schema documented, including all custom fields and non-standard configurations
• All active system integrations identified: EHR connections, clearinghouses, inventory platforms, reporting tools
• Custom workflow logic and business rules are documented before extraction begins
• Historical data retention requirements confirmed for each data category
• Legacy workarounds and manual override fields are flagged before field mapping begins
• Data volume baseline established for post-migration reconciliation
• Vendor documentation obtained for all systems being decommissioned
• End-of-life or unsupported system components are identified and flagged for priority extraction

 

Pay particular attention to sites that were acquired rather than built organically. Acquired locations often bring data structures from entirely different legacy systems that were partially converted at the time of acquisition and never fully normalized. Those sites frequently contain the deepest inconsistencies and get the least scrutiny because their volume is smaller or their operational footprint is quieter.

 

For LTC pharmacy operators, EMAR platform integrations deserve their own line in the integration inventory. A break in EMAR connectivity doesn’t surface as a pharmacy workflow problem; it surfaces as a medication administration gap at a nursing facility. Specialty pharmacies carry a different integration surface: hub service connections, limited distribution drug authorization platforms, and clinical management program systems that often exist outside the core dispensing platform entirely. Mail-fulfillment operations need to account for IVR systems, auto-refill engines, and address/shipping infrastructure that frequently aren’t documented as pharmacy integrations but fail immediately if they’re excluded from scope.

 

Domain 3: Compliance and Regulatory Readiness

Pharmacy data does not exist in a single regulatory lane. HIPAA governs how protected health information is handled, transferred, and safeguarded throughout the migration. DEA regulations govern controlled substance documentation and require that dispensing records remain complete and traceable without interruption. State pharmacy boards impose data retention and reporting requirements that vary by jurisdiction, and for an enterprise organization operating across multiple states, that variation is not a footnote. It is a compliance matrix that has to be confirmed location by location before migration begins.

The part of this domain that most commonly creates post-migration exposure is not malicious neglect. It is documentation that was accurate when it was written and has not been revisited since. A Business Associate Agreement signed for a previous system configuration. A HIPAA risk assessment completed before the current migration scope was defined. DEA documentation that reflects staff assignments from two years ago. Each of those documents creates a compliance baseline, and if that baseline does not reflect the actual migration being executed, it does not protect the organization in the way it appears to. Confirming compliance readiness means confirming it against the specific migration in front of you, not the general category of migration you have done before.

 

Checklist: Compliance and Regulatory Readiness

• Business Associate Agreement (BAA) executed with your migration partner before any PHI is accessed
• HIPAA risk assessment updated to reflect the current migration scope and timeline
• Controlled substance records audited and reconciled against DEA documentation requirements
• State board data retention requirements confirmed for all states in scope
• Audit trail integrity verified: access logs, dispensing records, and modification histories are fully traceable
• Data handling procedures documented and available for regulatory review
• Compliance sign-off obtained from your legal or compliance officer before go-live authorization
• Reporting functions tested to confirm continued accuracy post-migration
• 340B compliance records verified if applicable to your organization
• For specialty pharmacies: URAC or ACHC accreditation documentation reviewed and confirmed to reflect the current system configuration and migration scope

 

For organizations operating across multiple states, build a simple compliance matrix before this domain is considered complete. List each state in scope, the applicable board requirements, the retention timeline, and the name of the person who confirmed it. It takes an hour to build and can save weeks if you face a multi-state board inquiry after go-live.

For specialty pharmacies, confirm that URAC or ACHC accreditation documentation reflects the current system configuration and migration scope — accreditation audits following a migration will examine whether your operational processes and data handling procedures remained consistent through the transition.

 

Domain 4: Data Quality and Cleanliness Assessment

Most pharmacy organizations that have been running for five or more years have data problems they have learned to live with so completely that the problems have effectively become invisible. A pharmacist who has worked in the same system for four years knows intuitively which patients have duplicate profiles and how to navigate around them. The billing coordinator knows which insurance plan codes are outdated and corrects them manually before submitting claims without thinking twice about it. These accommodations are efficient in the environment where they were developed. They do not transfer.

When those same data problems move into a new system, the staff workarounds that made them manageable do not come with them. New staff, new workflows, and a new interface mean that what was an invisible inconvenience in the legacy system becomes a visible obstruction on day one. A pharmacy data migration checklist that does not include a formal data quality assessment before extraction begins is not protecting the organization from its legacy data problems. It is just transporting them into a more expensive environment.

The specific issues to look for are predictable: duplicate patient profiles created by name entry variations over the years, insurance plan records that are technically active in the system but have not been valid for years, prescriber credentials stored in inconsistent formats because different staff members entered them differently, NDC codes that reflect drug substitutions that were tracked in someone’s spreadsheet but never updated in the system itself. None of these are exotic data problems. They exist in virtually every pharmacy environment that has been running at scale for any meaningful length of time, and all of them are significantly easier to resolve before migration than after it.

 

Checklist: Data Quality Assessment

• Duplicate patient profile detection completed, with a documented resolution protocol for confirmed duplicates
• Insurance plan records reviewed: obsolete, terminated, and duplicate plans identified and resolved
• Prescriber credential formats standardized and validated against current NPI records
• NDC codes reviewed for consistency and alignment with current drug database standards
• Allergy alert records verified for completeness and accurate patient association
• Drug interaction flags reviewed to confirm accuracy before transfer
• Legacy notes fields evaluated for operational relevance before migration
• Controlled substance record counts reconciled before extraction
• Pricing tables and formulary configurations reviewed for accuracy
• Data quality baseline report generated and reviewed by clinical and operational stakeholders
• For LTC operators: cycle fill records and per-facility formulary configurations reviewed and explicitly mapped to destination system structures
• For specialty pharmacies: patient adherence program records and prior authorization histories inventoried and confirmed in scope — these are frequently stored in auxiliary systems
• For mail-fulfillment: auto-refill preference records and 90-day supply adjudication histories reviewed for field mapping before extraction

 

The investment in pre-migration data cleansing pays off in ways that extend well beyond a smooth go-live. Modern pharmacy platforms are architected to leverage clean, standardized data for analytics, automation, and performance reporting. If the data that enters those systems is fragmented or inconsistently structured, it constrains what those tools can do from the start. Treating data quality as a migration prerequisite rather than a post-go-live cleanup project is one of the highest-return decisions in the entire pre-migration process.

 

For LTC operators, cycle fill records and per-facility formulary configurations require dedicated review — these structures frequently don’t have direct equivalents in the destination system and need explicit field mapping before extraction begins. Specialty pharmacies should audit patient adherence program records and prior authorization histories before migration — these are frequently stored in auxiliary systems that get treated as outside migration scope and then become unreachable after cutover. Mail-fulfillment operations carry auto-refill preference records and 90-day supply adjudication histories that don’t map cleanly to retail transaction structures; confirming field mappings for these before extraction prevents reconciliation problems that are particularly difficult to untangle at high transaction volumes.

 

Domain 5: Security and Access Control Architecture

A migration creates security exposure that does not exist during normal operations, and it does so in ways that are easy to underestimate if security architecture is not explicitly on the pre-migration agenda. Data moving between systems passes through staging environments where access controls may not mirror production. Validation work sometimes requires temporary elevated permissions for people who would not normally have them. Third-party migration partners need access to PHI that they would not touch in any other context. Each of those conditions is a normal part of the migration process and a potential vulnerability if it is not actively managed.

What makes this domain particularly important for enterprise organizations is the regulatory consequence of getting it wrong. A PHI exposure during migration is not a situation where ambiguity works in your favor. Regulators will ask whether adequate safeguards were in place before data entered the migration environment, and the answer will be found in your pre-migration security documentation, or the absence of it. Building that documentation is not bureaucratic overhead. It is the evidence that protects your organization if something goes wrong and the foundation that prevents most of the things that could.

 

Checklist: Security Architecture

• End-to-end encryption confirmed for all data in transit during extraction, transfer, and loading
• Secure staging environment provisioned with access limited to authorized personnel only
• Role-based access controls are configured and tested before any PHI enters the migration environment
• Multi-factor authentication is enabled for all personnel with access to migration systems
• Activity logging is enabled across all migration stages: extraction, transformation, validation, and go-live
• Network security validated for cloud-based migration pathways
• Penetration testing or security validation is completed on the staging environment before production data is loaded
• Incident response protocol defined and distributed before go-live
• Vendor security certifications reviewed and confirmed current

 

Role-based access controls deserve particular attention during migrations because they tend to get configured once and not revisited. As the project progresses and personnel assignments shift, permissions that were appropriate at the start of the migration may not be appropriate three weeks in. Build a schedule to review and confirm access controls at each major milestone, not just at the beginning of the project.

 

Domain 6: Stakeholder Alignment and Team Readiness

A migration can be technically complete in every meaningful sense and still produce a difficult go-live if the people who need to operate the new system are not genuinely ready to do so. This is one of the most human parts of the pharmacy data migration checklist, and it is also one of the most commonly underestimated. Training gets scheduled and completed. Staff attend. But completion and readiness are not the same thing, and in the operational complexity of go-live morning, the gap between them shows up in the form of phone calls, workarounds, and frustrated staff at locations that did not get the support they needed.

At the enterprise level, the challenge is compounded by geography and organizational hierarchy. The teams closest to leadership tend to get the most preparation attention. Remote locations, recently acquired sites, and lower-volume pharmacies often receive lighter treatment, which is exactly backwards from a risk perspective because those locations frequently have the least institutional resilience when something goes wrong. A single pharmacist operating a 12-hour shift at a location four states away needs to be just as prepared as the flagship location where the project team is physically present on go-live day.

 

Checklist: Stakeholder Alignment

• All department leads were briefed on the migration timeline, their responsibilities, and the go-live protocol
• IT helpdesk staffing confirmed, with escalation paths and rollback authority clearly defined
• Clinical staff training completed on new system workflows before go-live
• The billing team was trained with a specific focus on any changes to claims submission and adjudication processes
• Pharmacy operations staff confirmed competent on new dispensing and verification workflows
• Communication plan distributed to all staff covering go-live timing, what to expect, and who to contact
• The executive sponsor briefed on the readiness status before final authorization
• Third-party integration partners notified of cutover timing and confirmed ready
• Post-go-live support schedule published with named coverage for each location

 

One practical step that gets overlooked: confirm that every location knows not just what the new system does, but what is different from the old one. Staff who are experienced in the legacy system will instinctively reach for workflows that no longer exist in the same form. A focused communication that specifically addresses what has changed, rather than just how the new system works, reduces the number of support calls in the first 48 hours more than almost anything else.

 

Domain 7: Validation and Go-Live Authorization Criteria

There is a conversation that happens in many enterprise migrations, usually in the two weeks before the scheduled go-live date, that determines more about the outcome than almost anything that comes before it. Someone senior asks whether the timeline is still holding. The honest answer, based on the state of validation, is that it probably should not. The organizational answer, based on sunk costs and executive expectations, is that it will. Validation criteria get quietly adjusted to fit what the timeline can accommodate rather than what the data actually requires, and the migration proceeds on schedule into a go-live that reveals, in the first few hours of operation, the problems that a more rigorous validation window would have caught.

The way to prevent that conversation from determining your outcome is straightforward in principle, even if it requires discipline in practice: define what a passing validation looks like before the project timeline is set, not after. When the criteria for go-live authorization are documented in advance, with clinical, compliance, IT, and executive sign-off, they carry organizational weight that makes them harder to negotiate away under pressure. A formal go-live authorization gate is not bureaucratic caution. It is the mechanism that keeps a calendar date from overriding evidence of readiness.

 

Checklist: Validation and Go-Live Authorization

• Test migration completed in a non-production environment with outcomes formally documented
• Record count reconciliation completed: pre- and post-migration counts verified across all data categories
• Controlled substance records reconciled with documented sign-off from compliance
• Insurance plan mappings tested through real-world claim simulation
• Drug interaction alerts and allergy flags tested and confirmed active in the new system
• Reporting functions validated against pre-migration baselines: financial, compliance, and operational
• Parallel system operation completed if required by your validation protocol
• Rollback plan documented, tested, and accessible to authorized personnel with clear activation criteria
• Go-live authorization formally signed off by executive sponsor
• Post-go-live monitoring schedule defined with assigned personnel and escalation protocols

 

Record count reconciliation deserves more granularity than it typically gets. A 2% aggregate discrepancy might look acceptable until you understand where those records live. If the variance is concentrated in a specific patient cohort, such as long-term patients with complex medication histories and multiple active allergy flags, that is not a rounding error. Define acceptable tolerance by record category, with clinical input on which categories have zero tolerance, before testing begins rather than after the numbers come back.

 

The Day One Readiness Gate: Final 12-Point Confirmation

Run through this list in the 24 to 48 hours before cutover. Each item needs a confirmed yes and a name attached to it. If an item is open and cannot be resolved before go-live, that requires a documented decision, not an assumption that it will work itself out. The items that get assumed rather than confirmed are reliably the ones that surface as problems on go-live morning.

• All seven pharmacy data migration checklist domains confirmed complete with documented sign-off
• Test migration outcomes reviewed and approved by technical lead and compliance officer
• Record count reconciliation confirmed across all data categories
• Executive sponsor go-live authorization obtained in writing
• IT helpdesk and post-go-live support confirmed available and briefed at all locations
• Rollback plan confirmed operational and accessible to authorized personnel
• Staff training confirmed complete across every location and every affected role
• Third-party integration partners confirmed ready for post-cutover reconnection
• Compliance officer confirmation that controlled substance records are reconciled and complete
• Security team confirmation that encryption, access controls, and logging are active
• Communication sent to all staff confirming go-live timing and Day One contact protocols
• Post-go-live monitoring live with named personnel confirmed at their assigned stations

 

Where Enterprise Organizations Most Often Fall Short

The following patterns appear with enough consistency across enterprise migrations that they are worth naming directly. None of them require unusual circumstances to develop. They grow out of the ordinary pressures of large organizational projects: timeline constraints, distributed accountability, and the understandable human tendency to defer hard problems when the deadline is still weeks away.

Assigning Domains to Teams Instead of Named Individuals

Shared ownership of a checklist domain sounds collaborative and reasonable until something is unresolved and there is no clear person responsible for resolving it. When a domain belongs to a team, unresolved items collect quietly because everyone on the team is waiting for someone else to take the lead. Assign a named individual to every domain in this pharmacy data migration checklist. The accountability that comes with individual ownership is not a management formality. It is the mechanism that actually gets things done.

Letting the Timeline Shape the Validation Criteria

When validation criteria are written after the project schedule is locked, they are subtly shaped by what the schedule can support. A test migration that reveals a 3% record count discrepancy gets rationalized as within tolerance, not because it actually is, but because acknowledging it is not would require extending the timeline. Define your go-live criteria before the schedule is set. Once those criteria carry executive sign-off, they have organizational standing that makes them significantly harder to quietly adjust when the deadline is close and the pressure is high.

Trusting Compliance Documentation That Has Not Been Reviewed Recently

Organizations commonly have compliance documentation that was accurate and thorough when it was created and has not been revisited since. A Business Associate Agreement from 18 months ago, a HIPAA risk assessment that predates the current scope, DEA documentation that reflects staff assignments that have since changed. Each of these creates a paper compliance posture that does not reflect the actual migration being executed. Before this domain of the checklist is considered complete, someone needs to have read each document recently and confirmed that it covers what you are actually doing, not what you were doing when it was written.

Planning to Address Data Quality After Go-Live

The post-go-live environment is the worst possible context for data remediation. Operations are live, claims are being submitted, pharmacists are filling prescriptions, and the support team is managing whatever the first 48 hours of the new system has surfaced. There is no quiet window in which to work through duplicate patient records, inaccurate prescriber records or reconcile misaligned insurance plan codes. Every data quality problem deferred to after go-live will be harder to resolve after go-live, and some will cause patient-facing or financial consequences before they get addressed. The pre-migration window is the only time a clean, controlled resolution is actually available.

Assuming Consistency Across Sites That Was Never Verified

Enterprise organizations frequently assume that their locations are operating on consistent data structures because they are all running the same platform. What they are actually running is the same platform with years of site-level differences layered on top of it: locally customized fields, workarounds for legacy limitations, data entry conventions that developed independently at each location. A validation process that confirms readiness at one representative site and treats the rest as equivalent is not enterprise validation. Every location that enters the migration scope deserves its own data review, and the sites that seem the most straightforward are often the ones that yield the most unexpected findings.

 

Scoping the Migration Around the Dispensing System and Missing Everything Else

Retail pharmacy migrations can often be scoped tightly around the dispensing platform because that’s where most of the operational complexity lives. That assumption breaks down for specialty, LTC, and mail-fulfillment operations, where significant data and workflow complexity lives outside the core dispensing system. LTC operators have per-facility formularies and EMAR connectivity that make every facility in their book of business a distinct stakeholder. Specialty pharmacies have hub service records, limited distribution authorization data, and clinical management program histories in auxiliary systems that routinely get excluded from migration scope as “not pharmacy data.” Mail-fulfillment operations have auto-refill logic and patient preference records that exist at the intersection of the dispensing platform and the fulfillment infrastructure and can fall between systems entirely if no one explicitly owns them in the migration plan. Define migration scope by following the data, not the system boundaries.

 

Using This Checklist to Evaluate Your Migration Partner

The pharmacy data migration checklist above defines what needs to happen before go-live. Your migration partner is the team responsible for helping you execute it, and the depth of their answers to a few direct questions will tell you quickly whether their process is built around the same rigor this checklist requires or whether they are primarily focused on the technical transfer and leaving the readiness work to your internal team.

Ask them specifically: how do you approach the legacy system audit before field mapping begins? What does your data quality assessment protocol include, and when does it happen in the project timeline? How do you handle controlled substance record reconciliation, and who provides the compliance sign-off? What are your go-live authorization criteria, and who has the authority to delay cutover if those criteria are not met? What does your rollback plan look like, and what is the realistic activation timeline if something goes wrong after cutover?

A partner with genuine healthcare migration expertise will answer those questions with specificity, because they have built their process around them. A general IT migration vendor may handle the technical transfer competently while having no structured answer for the clinical, regulatory, and operational readiness questions that determine whether the transfer actually works for the people who have to use the system the next morning. The distinction matters, and it is not difficult to surface in a direct conversation.

 

Frequently Asked Questions

 

The Preparation Is the Migration

Most of what determines whether an enterprise pharmacy migration succeeds happens before the cutover date. The technical transfer, when it is preceded by thorough preparation, is often the most straightforward part of the entire process. It is the seven domains in this pharmacy data migration checklist that carry the real weight: the governance decisions that keep the project moving, the data quality work that determines what the new system actually performs like, the compliance confirmation that protects the organization before and after the transition, and the stakeholder readiness that determines whether the people operating the system on day one can do so with confidence.

Working through this checklist completely, with individual ownership on every domain and documented sign-off before go-live, is not a bureaucratic exercise. It is the practical work of protecting a significant organizational investment and ensuring that the modernization you planned for actually delivers what you planned for it to deliver.

 

InfoWerks Pharmacy Data Migration

If your organization is preparing for enterprise pharmacy data migration and you want to work through these domains with a team that has executed them across health systems, retail chains, LTC operators, specialty pharmacies, mail-fulfillment operations, and multi-location independents, InfoWerks is ready to help. Visit infowerks.com or call 702.914.9910 to start the conversation.